Literature DB >> 19590257

Specificity of Gbetagamma signaling depends on Galpha subunit coupling with G-protein-sensitive K(+) channels.

Xian Geng1, Xiao-na Du, Radda Rusinova, Bo-yi Liu, Fang Li, Xuan Zhang, Xing-juan Chen, Diomedes E Logothetis, Hai-lin Zhang.   

Abstract

Many neurotransmitters activate G-protein-gated inwardly rectifying K(+) (Kir3) channels by stimulating G-protein-coupled receptors. However, in native systems, only receptors coupled to pertussis-toxin (PTX)-sensitive G proteins (Gi/Go) have been shown to be able to activate Kir3 channels through the betagamma subunits of G proteins (Gbetagamma), whereas activation of receptors coupled to PTX-insensitive G proteins such as Gq or Gs do not activate Kir3 channels. The question remains as to how signaling specificity is achieved and what are its key determinants. In this study, we have used the Xenopus oocyte expression system to investigate specific activation of Kir3 channels by heterotrimeric G proteins. We have demonstrated the activation of Kir3.4 channels by agonist stimulation of non-PTX-sensitive G proteins under conditions of Galpha subunit overexpression. We present evidence to suggest a key role for the coupling efficiency of Galpha subunits in determining the specificity of Gbetagamma signaling to the channel.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19590257     DOI: 10.1159/000227772

Source DB:  PubMed          Journal:  Pharmacology        ISSN: 0031-7012            Impact factor:   2.547


  2 in total

Review 1.  Emerging roles for G protein-gated inwardly rectifying potassium (GIRK) channels in health and disease.

Authors:  Christian Lüscher; Paul A Slesinger
Journal:  Nat Rev Neurosci       Date:  2010-04-14       Impact factor: 34.870

2.  Signaling Mechanism of Cannabinoid Receptor-2 Activation-Induced β-Endorphin Release.

Authors:  Fang Gao; Ling-Hong Zhang; Tang-Feng Su; Lin Li; Rui Zhou; Miao Peng; Cai-Hua Wu; Xiao-Cui Yuan; Ning Sun; Xian-Fang Meng; Bo Tian; Jing Shi; Hui-Lin Pan; Man Li
Journal:  Mol Neurobiol       Date:  2015-06-25       Impact factor: 5.590

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.